Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1996
11/19/1996US5576337 Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y
11/19/1996US5576323 Excitatory amino acid receptor antagonists
11/19/1996US5576321 Compounds having effects on serotonin-related systems
11/19/1996US5576320 1-heteruarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
11/19/1996US5576318 For treatment of central nervous system disorders
11/19/1996US5576289 Methods for treating motor deficits
11/19/1996US5576024 Buffered matrix aspirin
11/19/1996CA2109613C Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
11/19/1996CA2106200C Stereoselective preparation of substituted piperidines
11/14/1996WO1996035805A2 Tripeptidylpeptidase inhibitors
11/14/1996WO1996035776A1 Isolating and culturing schwann cells
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035689A1 Novel deazapurine derivatives; a new class of crf1 specific ligands
11/14/1996WO1996035671A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035670A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035666A1 Benzyl piperidine derivatives as pharmaceutical agents
11/14/1996WO1996035467A1 Coarse spray delivery of functional biologic materials
11/14/1996WO1996035446A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996WO1996035441A1 Pharmaceutical compositions for the treatment of alcohol addiction
11/14/1996WO1996031208A3 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/14/1996WO1996022068A3 Methods and pharmaceutical compositions employing desmethylselegiline
11/14/1996CA2221035A1 Tripeptidylpeptidase inhibitors
11/14/1996CA2220897A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220538A1 .beta.-adrenergic agonists
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2220504A1 Benzyl piperidine derivatives as pharmaceutical agents
11/14/1996CA2220399A1 .beta.-adrenergic agonists
11/14/1996CA2218879A1 Coarse spray delivery of functional biologic materials
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996CA2194756A1 Novel deazapurine derivatives; a new class of crf1 specific ligands
11/13/1996EP0742216A2 Cyclic amide derivatives
11/13/1996EP0742207A1 2-(Indan-1-one-2-yl-alkyl)-1-phenylalkyl-piperidines and processes for their preparation
11/13/1996EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
11/13/1996EP0741743A1 Cyclic neurokinin a antagonists
11/13/1996EP0741725A1 Indole derivatives as 5-ht 1? agonists
11/13/1996EP0741724A1 Neuroprotective chroman compounds
11/13/1996EP0741723A1 Triazole derivatives
11/13/1996EP0741722A1 Triazole derivatives
11/13/1996EP0741721A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists
11/13/1996EP0741709A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
11/13/1996EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0683777B1 Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-[n-carboxamido]carboxamides as intiinflammatory agents
11/13/1996CN1135754A Therapeutic agents
11/13/1996CN1135753A Imidazo |1,5-1¨ quinolines for treatment of anxiety and sleep disorders
11/13/1996CN1135750A Novel carbamate compounds and processes for preparing the same
11/13/1996CN1135480A Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound
11/13/1996CN1135350A Method for preparation of medicine good for memory
11/12/1996US5574170 Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration
11/12/1996US5574158 Crypt compounds, nervous system disorders, chelate compounds
11/12/1996US5574070 Substituted guanidines having high binding to the sigma receptor and the use thereof
11/12/1996US5574060 Selective inhibitors of biogenic amine transporters
11/12/1996US5574055 Cognitive and neurodegenerative disorders
11/12/1996US5574046 Heteroaryl amines as novel acetylcholinesterase inhibitors
11/12/1996US5574038 5,6-cyclicimidazo [1,5-a] Quinoxalines
11/12/1996US5574035 S-timolol hemihydrate composition and method of preparation therefor
11/12/1996US5574032 Antipsychotic agents, analgesics
11/12/1996US5574031 Piperazine carboxamides
11/12/1996CA2105302C 1-azabicyclo¬3.2.2.|nonan-3-amine derivatives
11/12/1996CA2069910C Muscarinic receptor antagonists
11/12/1996CA2028440C Naphthyloxazolidone derivatives
11/12/1996CA2012295C Pyrrolidine derivatives
11/11/1996EP0748792A4 Calcium ketopantothenate with acetylating properties
11/07/1996WO1996034865A1 Novel heterocyclic chemistry
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034863A1 Novel heterocyclic chemistry
11/07/1996WO1996034857A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034849A1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/06/1996EP0740938A2 Proline and 4-hydroxyproline as therapeutic agents
11/06/1996EP0740936A2 Use of benzopyran derivatives for the manufacture of medicaments for the treatment of diseases connected with the sodium independent Cl-/HCO3- exchanger
11/06/1996EP0740658A1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
11/06/1996EP0740657A1 4-arylisoindole analgesics
11/06/1996EP0740654A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
11/06/1996EP0729361A4 Method of treating neurological disorders
11/06/1996CN1135219A Anthracycline derivatives
11/06/1996CN1135218A Piperidine derivatives
11/06/1996CN1135216A Optically active imidazolidinone derivative and process for prodn. of same
11/06/1996CN1135215A Imidazolidinone derivative, acid-addition salt therefor, and remedy for senile dementia
11/06/1996CN1135209A Novel phenylalkylaminoalcohol carbamates and process for prepn. of same
11/06/1996CN1135180A Use of penciclorin for the treatment of post-therapeutic neuralgia
11/06/1996CN1134938A Novel alkylated (hetero) cyclic compounds, process for their prepn. and pharmaceutical compositions contg. same
11/06/1996CA2175747A1 Benzopyrane derivatives used for preparing pharmaceutical compositions used in the treatment of pathology related to na+ independent cl-/hco3- exchanger
11/05/1996US5571942 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
11/05/1996US5571918 Reacting 3-hydroxy-3-mercaptomethylquinuclidine and a carbonyl compound in the presence of a catalyst
11/05/1996US5571840 Method for treating central nervous system ischemia
11/05/1996US5571833 Tryptamine analogues, their synthesis and their use as 5-HT1 -like or 5-HT2 receptor agonists
11/05/1996US5571828 N-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-2,3-napthalimides and related compounds and their therapeutic utility
11/05/1996US5571826 Heterocyclic compounds and their preparation and use
11/05/1996US5571823 Pharmacological treatment of ocular development
11/05/1996US5571814 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]phthalimides and related compounds and their therapeutic utility
11/05/1996US5571803 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
1 ... 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 ... 1833